03/11/2015 - 12:50pm

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

03/11/2015 - 12:40pm

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

03/11/2015 - 12:27pm

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

03/11/2015 - 11:58am

The supplement industry on Wednesday called into question the validity of the New York Attorney General's investigtation into botanical dietary supplements with a white paper that outlines the potential shortfalls of the testing methodology used. 

03/11/2015 - 10:42am

The Female Health Company launched an online store to promote its FC2 Female Condom. 

03/10/2015 - 3:38pm

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

03/10/2015 - 1:19pm

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

03/09/2015 - 2:40pm

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

03/09/2015 - 1:47pm

Primary care physicians are facing a patient overload and, in some cases, they are referring their patients elsewhere for medical care.